p21ras protein expression in benign and malignant
- 1 October 1988
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 156 (2), 147-153
- https://doi.org/10.1002/path.1711560209
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cellular oncogenes in neoplasia.Journal of Clinical Pathology, 1987
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Prevalence of ras gene mutations in human colorectal cancersNature, 1987
- Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast diseaseThe Journal of Pathology, 1986
- Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.Journal of Clinical Pathology, 1986
- Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.Journal of Clinical Pathology, 1986
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985
- The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activityNature, 1984
- Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteinsNature, 1984
- Expression of Cellular Oncogenes in Human MalignanciesScience, 1984